Insiders / Deerfield Mgmt, L.P. / Activity
Activity — Deerfield Mgmt, L.P.
22 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Buy | LRMR Larimar Therapeutics, Inc. Common Stock | $10.00M | +2.0M +47.53% | 6,207,982 5.98% of shares | high |
| Feb 27, 2026 | Buy | LRMR Larimar Therapeutics, Inc. Common Stock | $5.42M | +1.1M +11.36% | 10,622,957 10.23% of shares | high |
| Feb 27, 2026 | Buy | LRMR Larimar Therapeutics, Inc. Common Stock | $5.42M | +1.1M +11.36% | 10,622,928 10.23% of shares | high |
| Feb 27, 2026 | Buy | LRMR Larimar Therapeutics, Inc. Common Stock | $4.16M | +832K +11.36% | 8,153,107 7.85% of shares | high |
| Jun 16, 2026 | Grant | NUVL Nuvalent, Inc. Class A Common Stock | $0 | +3K | 3,444 <0.01% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Series D Preferred Stock | — | -465K -100.00% | 0 0.00% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Series D Preferred Stock | — | -465K -100.00% | 0 0.00% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Series C Preferred Stock | — | -247K -100.00% | 0 0.00% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Series C Preferred Stock | — | -247K -100.00% | 0 0.00% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Series B Preferred Stock | — | -144K -100.00% | 0 0.00% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Series B Preferred Stock | — | -144K -100.00% | 0 0.00% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Series A Preferred Stock | — | -166K -100.00% | 0 0.00% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Series A Preferred Stock | — | -166K -100.00% | 0 0.00% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Voting Common Stock | — | +407K +76.35% | 940,352 0.77% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Voting Common Stock | — | +407K +76.35% | 940,352 0.77% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Voting Common Stock | — | +261K +95.87% | 533,220 0.44% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Voting Common Stock | — | +261K +95.87% | 533,220 0.44% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Voting Common Stock | — | +149K +121.34% | 272,228 0.22% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Voting Common Stock | — | +149K +121.34% | 272,228 0.22% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Voting Common Stock | — | +123K | 122,990 0.10% of shares | low |
| Jun 11, 2026 | Other | PBLS Parabilis Medicines, Inc. Voting Common Stock | — | +123K | 122,990 0.10% of shares | low |
| May 19, 2026 | Grant | LRMR Larimar Therapeutics, Inc. Stock Option (Right to Buy) | — | +55K | 55,150 0.05% of shares | low |